131 related articles for article (PubMed ID: 18271919)
1. Loss of nephronectin promotes tumor progression in malignant melanoma.
Kuphal S; Wallner S; Bosserhoff AK
Cancer Sci; 2008 Feb; 99(2):229-33. PubMed ID: 18271919
[TBL] [Abstract][Full Text] [Related]
2. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
3. Expression of Dickkopf genes is strongly reduced in malignant melanoma.
Kuphal S; Lodermeyer S; Bataille F; Schuierer M; Hoang BH; Bosserhoff AK
Oncogene; 2006 Aug; 25(36):5027-36. PubMed ID: 16568085
[TBL] [Abstract][Full Text] [Related]
4. Cadherin-7 interacts with melanoma inhibitory activity protein and negatively modulates melanoma cell migration.
Winklmeier A; Contreras-Shannon V; Arndt S; Melle C; Bosserhoff AK
Cancer Sci; 2009 Feb; 100(2):261-8. PubMed ID: 19200257
[TBL] [Abstract][Full Text] [Related]
5. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
6. TANGO is a tumor suppressor of malignant melanoma.
Arndt S; Bosserhoff AK
Int J Cancer; 2006 Dec; 119(12):2812-20. PubMed ID: 17044017
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of POEM: a novel adhesion molecule that interacts with alpha8beta1 integrin.
Morimura N; Tezuka Y; Watanabe N; Yasuda M; Miyatani S; Hozumi N; Tezuka Ki K
J Biol Chem; 2001 Nov; 276(45):42172-81. PubMed ID: 11546798
[TBL] [Abstract][Full Text] [Related]
8. GLI2-mediated melanoma invasion and metastasis.
Alexaki VI; Javelaud D; Van Kempen LC; Mohammad KS; Dennler S; Luciani F; Hoek KS; Juàrez P; Goydos JS; Fournier PJ; Sibon C; Bertolotto C; Verrecchia F; Saule S; Delmas V; Ballotti R; Larue L; Saiag P; Guise TA; Mauviel A
J Natl Cancer Inst; 2010 Aug; 102(15):1148-59. PubMed ID: 20660365
[TBL] [Abstract][Full Text] [Related]
9. Expression of integrin alpha10 is induced in malignant melanoma.
Wenke AK; Kjellman C; Lundgren-Akerlund E; Uhlmann C; Haass NK; Herlyn M; Bosserhoff AK
Cell Oncol; 2007; 29(5):373-86. PubMed ID: 17726260
[TBL] [Abstract][Full Text] [Related]
10. Loss of maspin expression contributes to a more invasive potential in malignant melanoma.
Denk AE; Bettstetter M; Wild PJ; Hoek K; Bataille F; Dietmaier W; Bosserhoff AK
Pigment Cell Res; 2007 Apr; 20(2):112-9. PubMed ID: 17371437
[TBL] [Abstract][Full Text] [Related]
11. Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression.
Rutka JT; Muller M; Hubbard SL; Forsdike J; Dirks PB; Jung S; Tsugu A; Ivanchuk S; Costello P; Mondal S; Ackerley C; Becker LE
J Neuropathol Exp Neurol; 1999 Feb; 58(2):198-209. PubMed ID: 10029102
[TBL] [Abstract][Full Text] [Related]
12. Expression of POEM, a positive regulator of osteoblast differentiation, is suppressed by TNF-α.
Tsukasaki M; Yamada A; Suzuki D; Aizawa R; Miyazono A; Miyamoto Y; Suzawa T; Takami M; Yoshimura K; Morimura N; Yamamoto M; Kamijo R
Biochem Biophys Res Commun; 2011 Jul; 410(4):766-70. PubMed ID: 21689636
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
14. Gastrin exerts pleiotropic effects on human melanoma cell biology.
Mathieu V; Mijatovic T; van Damme M; Kiss R
Neoplasia; 2005 Oct; 7(10):930-43. PubMed ID: 16242076
[TBL] [Abstract][Full Text] [Related]
15. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
Kuphal S; Wallner S; Bosserhoff AK
Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
[TBL] [Abstract][Full Text] [Related]
16. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
17. Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.
Dilmac S; Erin N; Demir N; Tanriover G
Pathol Oncol Res; 2018 Jul; 24(3):679-688. PubMed ID: 28842827
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
[TBL] [Abstract][Full Text] [Related]
19. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta suppresses POEM expression through ERK1/2 and JNK in osteoblasts.
Miyazono A; Yamada A; Morimura N; Takami M; Suzuki D; Kobayashi M; Tezuka K; Yamamoto M; Kamijo R
FEBS Lett; 2007 Nov; 581(27):5321-6. PubMed ID: 17977532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
